Literature DB >> 24872580

Defective viral genomes: critical danger signals of viral infections.

Carolina B López1.   

Abstract

Viruses efficiently block the host antiviral response in order to replicate and spread before host intervention. The mechanism initiating antiviral immunity during stealth viral replication is unknown, but recent data demonstrate that defective viral genomes generated at peak virus replication are critical for this process in vivo. This article summarizes the supporting evidence and highlights gaps in our understanding of the mechanisms and impact of immunostimulatory defective viral genomes generated during natural infections.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24872580      PMCID: PMC4136278          DOI: 10.1128/JVI.00707-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.

Authors:  Jenish R Patel; Ankur Jain; Yi-ying Chou; Alina Baum; Taekjip Ha; Adolfo García-Sastre
Journal:  EMBO Rep       Date:  2013-07-12       Impact factor: 8.807

Review 2.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

3.  Defective interfering particles from poliovirus vaccine and vaccine reference strains.

Authors:  L C McLaren; J J Holland
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

4.  Interferon induction by viruses. IV. Sindbis virus: early passage defective-interfering particles induce interferon.

Authors:  F J Fuller; P I Marcus
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

5.  The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells.

Authors:  M D Johnston
Journal:  J Gen Virol       Date:  1981-09       Impact factor: 3.891

6.  Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.

Authors:  Xiomara Mercado-López; Christopher R Cotter; Won-Keun Kim; Yan Sun; Luis Muñoz; Karla Tapia; Carolina B López
Journal:  Vaccine       Date:  2013-10-05       Impact factor: 3.641

Review 7.  Intracellular pathogen detection by RIG-I-like receptors.

Authors:  Evelyn Dixit; Jonathan C Kagan
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

8.  MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles.

Authors:  Jacob S Yount; Leonid Gitlin; Thomas M Moran; Carolina B López
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 9.  Viral tricks to grid-lock the type I interferon system.

Authors:  Gijs A Versteeg; Adolfo García-Sastre
Journal:  Curr Opin Microbiol       Date:  2010-06-10       Impact factor: 7.934

10.  Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Authors:  Karla Tapia; Won-Keun Kim; Yan Sun; Xiomara Mercado-López; Emily Dunay; Megan Wise; Michael Adu; Carolina B López
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

View more
  35 in total

1.  Nonlinear trade-offs allow the cooperation game to evolve from Prisoner's Dilemma to Snowdrift.

Authors:  Lin Chao; Santiago F Elena
Journal:  Proc Biol Sci       Date:  2017-05-17       Impact factor: 5.349

Review 2.  What Really Rigs Up RIG-I?

Authors:  Sailen Barik
Journal:  J Innate Immun       Date:  2016-07-21       Impact factor: 7.349

Review 3.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

4.  The brain parenchyma has a type I interferon response that can limit virus spread.

Authors:  Eugene Drokhlyansky; Didem Göz Aytürk; Timothy K Soh; Ryan Chrenek; Elaine O'Loughlin; Charlotte Madore; Oleg Butovsky; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-15       Impact factor: 11.205

Review 5.  To assemble or not to assemble: The changing rules of pneumovirus transmission.

Authors:  Nicolás Cifuentes-Muñoz; Rebecca Ellis Dutch
Journal:  Virus Res       Date:  2019-03-05       Impact factor: 3.303

6.  Defective Viral Genomes Alter How Sendai Virus Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production of Viral Particles among Infected Cells.

Authors:  Emmanuelle Genoyer; Carolina B López
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.

Authors:  Udaya S Rangaswamy; Weijia Wang; Xing Cheng; Patrick McTamney; Danielle Carroll; Hong Jin
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions.

Authors:  Giulia Fabozzi; Andrew J Oler; Poching Liu; Yong Chen; Samuel Mindaye; Michael A Dolan; Heather Kenney; Marjan Gucek; Jun Zhu; Ronald L Rabin; Kanta Subbarao
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 9.  The innate immune response to RSV: Advances in our understanding of critical viral and host factors.

Authors:  Yan Sun; Carolina B López
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

Review 10.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.